1111 Lymph node-targeted lipid nanoparticles with dendritic cell tropism effectively induce memory precursor effector cells and boost mRNA cancer vaccine efficacy

效应器 向性 淋巴结 树突状细胞 癌症研究 细胞生物学 生物 病毒学 免疫学 免疫系统 病毒
作者
Yujin Kim,James Jaehyun Moon
出处
期刊:Journal for ImmunoTherapy of Cancer [BMJ]
卷期号:: A1232-A1232 被引量:1
标识
DOI:10.1136/jitc-2024-sitc2024.1111
摘要

Background The coronavirus disease 2019 (COVID-19) pandemic has facilitated the clinical implementation of messenger RNA (mRNA) vaccines. The successful development of lipid nanoparticles (LNPs)-based mRNA vaccines, such as Spikevax (Moderna) and Comirnaty (BioNTech/Pfizer), has established LNPs as the preferred mRNA delivery carrier, suggesting broader applications beyond infectious diseases, notably in cancer vaccination. However, conventional LNP mRNA vaccines lack cell specificity, particularly for dendritic cells (DCs), which are crucial for eliciting antitumor immune responses,1 2 and predominantly distributed to injection sites and non-lymphoid organs. This highlights the need for a mRNA delivery platform that can efficiently target lymphoid organs and enhancing the antitumor efficacy of mRNA vaccines.3 In this study, we report a new LNP for lymph node-specific delivery and DC tropism to enhance the efficacy of mRNA cancer vaccines. Methods A library of LNPs loaded with firefly luciferase encoding mRNA was constructed by systematically modulating ionizable lipids, helper lipids, and PEGylated lipids along with their compositions (figure 1A). In vitro screening using mouse bone marrow-derived dendritic cells (BMDCs) identified LNPs with enhanced mRNA transfection efficiency specifically in DCs. We evaluated LNP-mediated antigen mRNA expression, antigen presentation, and T cell priming in vitro. In vivo imaging (IVIS) was performed to assess lymph node delivery and mRNA expression of LNPs. The antitumor efficacy of LNP mRNA vaccines was assessed in a murine melanoma B16F10 model expressing a model ovalbumin antigen (B16F10-OVA). We also examined the magnitude and quality of antitumor immune responses in mice post mRNA-LNP vaccination. Results Among the various LNP formulations screened, one top candidate, designated as LNPA, significantly enhanced antigen presentation in DCs and CD8+ T cell priming in vitro, compared to the LNP formulation utilized in Spikevax (Moderna) (figure 1B). Additionally, this LNPA exhibited superior mRNA expression and delivery to lymph nodes upon subcutaneous administration in mice, compared to the Spikevax LNP formulation. Further analysis revealed that LNPA significantly increased DC-specific mRNA expression within the lymph nodes. In an antitumor efficacy study conducted against an established B16F10-OVA tumor model, immunization with LNPA significantly inhibited tumor growth and increased the survival rate of tumor-bearing mice while markedly increasing antigen-specific memory precursor effector cells (MPECs; CD127+KLRG1-OT-I Tetramer+) (figure 1C). Conclusions We developed a lymph node-targeting LNP mRNA vaccine with DC tropism. This system is expected to serve as a versatile vaccine platform for combating cancer and other diseases. Acknowledgements This work was supported by NIH (R01AI127070, R01CA210273, U01CA210152, R01DK108901, R01DE026728, R01DE030691, R01DE031951) and the University of Michigan Rogel Cancer Center Support Grant (P30CA46592). References Zhu Y, Ma J, Shen R, et al. Screening for lipid nanoparticles that modulate the immune activity of helper T cells towards enhanced antitumour activity. Nat Biomed Eng 2024;8(5):544–560. DOI: 10.1038/s41551-023-01131-0. Yin D, Zhong Y, Ling S, et al. Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers. Nat Biomed Eng 2024. DOI: 10.1038/s41551-024-01208-4. Chen J, Ye Z, Huang C, et al. Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response. Proc Natl Acad Sci U S A 2022;119(34):e2207841119. DOI: 10.1073/pnas.2207841119.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
说书人发布了新的文献求助50
1秒前
1秒前
超级冬寒完成签到,获得积分10
1秒前
多绚题发布了新的文献求助10
1秒前
1秒前
2秒前
sudor123456完成签到,获得积分10
2秒前
2秒前
3秒前
CipherSage的应助被trx采纳,获得10
5秒前
aiheihei完成签到 ,获得积分10
5秒前
5秒前
跳跃靖完成签到,获得积分20
6秒前
冰棍发布了新的文献求助10
7秒前
7秒前
何澳奇发布了新的文献求助10
8秒前
CY发布了新的文献求助10
8秒前
sharry完成签到 ,获得积分10
9秒前
dd发布了新的文献求助10
9秒前
呆萌的豌豆完成签到,获得积分10
9秒前
害怕的凤妖完成签到,获得积分10
10秒前
wan完成签到 ,获得积分10
10秒前
赘婿的应助被JimmyFun采纳,获得10
10秒前
瘦瘦的曲奇完成签到 ,获得积分10
12秒前
12秒前
李健的应助被Jie采纳,获得10
12秒前
酆子贤完成签到,获得积分10
12秒前
13秒前
lily完成签到,获得积分10
13秒前
ding的应助被彩色脆霜采纳,获得10
13秒前
秋风的应助被顺科研采纳,获得20
14秒前
tt耶发布了新的文献求助10
14秒前
Zzzn完成签到,获得积分10
14秒前
青柠完成签到,获得积分10
14秒前
务实的忆雪的应助被感叹采纳,获得10
15秒前
恣意完成签到 ,获得积分10
15秒前
闹斯特麻麻关注了科研通微信公众号
15秒前
duola完成签到,获得积分10
15秒前
结实的含之完成签到,获得积分10
15秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181460
求助须知:如何正确求助?哪些是违规求助? 9571362
关于积分的说明 21817839
捐赠科研通 7777938
什么是DOI,文献DOI怎么找? 3433494
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479550